Source: Korea Newswire

Press Release: QPS : QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis

QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of its pharmacology disease models portfolio to include highly ...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Benjamin M. Chien's photo - Chairman & CEO of QPS

Chairman & CEO

Benjamin M. Chien

CEO Approval Rating

79/100

Read more